Company Research Report: Applied StemCell, Inc.
Company Overview
Name: Applied StemCell, Inc.
Mission: To empower scientists to discover and develop therapeutics faster, more cost-effectively, and with higher success rates by providing iPSC and gene editing platforms, services, and GMP manufacturing expertise that increase biological relevance and engineering precision.
Founded: 2008
Founder: Ruby Yanru Tsai, Ph.D.
Key People in the Company:
- Ruby Yanru Tsai, Ph.D. – CEO, Founder, and President
- Timothy J. Largen – Chief Operating Officer
- Tammy Cameron – Chief Financial Officer
- Alfonso Farruggio, Ph.D. – Head of Research and Development
- Mike Yurkovich, Ph.D. – Vice President of Sales
- Simon Wu, Ph.D. – Director, Project Management and Technical Operation
Headquarters: 521 Cottonwood Dr. Suite #111, Milpitas, California 95035, USA
Number of Employees: No information is available.
Revenue: No information is available.
Known For: Applied StemCell is known for its contributions to iPSC and gene editing technology, providing innovative solutions for autologous and allogeneic discovery and development. The company's products and services enable a broad spectrum of activities from basic research to GMP manufacturing and biobanking.
Products
Gene Editing Platforms
- CRISPR, Mad7, TARGATT™ Technology
- Description: Advanced platforms for creating custom gene editing solutions.
- Key Features: High precision editing capabilities, including large cargo knock-ins and base editing.
iPSC Services
- iPSC Generation and Differentiation
- Description: Fast and reliable generation and targeted differentiation of iPSCs.
- Key Features: Use of proprietary technologies to ensure swift and precise outcomes.
cGMP Services
- cGMP Cell Banking and Expansion
- Description: Customizable services for GMP cell banking in California.
- Key Features: Focus on size, concentration, and quality control during banking and expansion processes.
Rodent Models and Studies
- Custom Mouse and Rat Models
- Description: Development of off-the-shelf and custom animal models for nonclinical studies.
- Key Features: Availability of models for safety, pharmacokinetics, and efficacy studies.
Featured Products
- GMP iPSC Cell Line
- Key Features: Proven genomic stability, stable transgene expression, covered by US FDA DMF.
- GMP-Grade TARGATT™ iPSC Cell Line
- Key Features: Ready for gene knock-in with single copy efficiency, research-grade line available.
- iPSC-derived Cells and MEF Cells
- Key Features: Ready-to-use cells for various research applications.
Recent Developments
New Product Launches
- GMP TARGATT iPSCs (Coming Soon)
New Features
- HLA-F Engineered Universal Donor Cells: Patent approval for new cell transplantation therapy solutions.
Partnerships and Leadership
- Strengthening of executive leadership with new appointments, including Todd Garland.
- Participation in BIO Partnering @JPM Week to foster industry collaborations.
Company Milestones
- Applied StemCell has announced over recent years new patents and industry engagements, including their participation in global scientific conventions and summits, to showcase their iPSC platform and cell manufacturing capabilities.
Contact Information
Address:
Applied StemCell, Inc.
521 Cottonwood Dr. Suite #111
Milpitas, California 95035, USA
Email: info@appliedstemcell.com
Phone: 1-866-497-4180, 1-650-800-7179
Social Media:
- [Facebook](#)
- [Twitter/X](#)
- [LinkedIn](#)
Note: This report compiles available data on Applied StemCell, Inc. as represented in the provided information. Certain fields lack specific data and are accordingly noted as not available.
